AB Sciex is doing business as SCIEX. © 2010-2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license. Beckman Coulter® is being used under license. Product(s) may not be available in all countries. For information on availability, please contact your local representative. For research use only. Not for use in diagnostic procedures.
SCIEX industrialized proteomics solutions, using SWATH® Acquisition-based workflows and powered by the OneOmics™ Project, will enable large scale proteome studies to advance cancer research
Framingham, MA and Sydney, Australia — SCIEX, a global leader in life science analytical technologies, today announced their alliance with Children’s Medical Research Institute (CMRI) to equip The Australian Cancer Research Foundation International Centre for the Proteome of Cancer (ProCan™) facility with the solutions and tools required for the advancement of their large-scale proteomic profiling studies. These studies will profile thousands of tumour samples per year, enable discoveries around the causes of cancer, provide guidance of cancer treatment options, and work to produce standard operating procedures for other facilities around the world. ProCan will be established with $10 million in seed money from The Australian Cancer Research Foundation to purchase the SCIEX equipment.
The agreement provides ProCan with the high sample throughput required for the industrialisation of proteomics via a large suite of SCIEX TripleTOF® 6600 mass spectrometers and NanoLC 400 HPLCs, to create one of the world's largest scale implementations of the SCIEX next-generation proteomics solution, featuring SWATH® Acquisition and OneOmics cloud computing. Additionally ProCan will benefit from SCIEX’s exclusive collaborators, Pressure Biosciences and Beckman Coulter, using Pressure Cycling Technology and liquid handling workstations for increased protein quantitation and reproducibility.
"Large-scale proteomics studies have great potential to improve our understanding of cancer at the molecular level, but are subject to significant variability caused in sample preparation, data acquisition and interpretation," said Chris Radloff, Global Vice President and General Manager of the LC-MS Business at SCIEX. "Through our partnership with CMRI and the designation of ProCan as a SCIEX Centre of Innovation in Precision Medicine, SCIEX solutions reduce that variability and enable higher sample throughput, which will help to accelerate cancer research and precision medicine at large."
"Collaborating with SCIEX will enable ProCan to accomplish our vision of one day, delivering a proteomics report on every clinician's desk," said Professor Phil Robinson, Head of the Cell Signalling Unit at CMRI and co-developer of ProCan with Professor Roger Reddel, Head of CMRI's Cancer Research Unit. "The unique industrial proteomics platform we are developing will unlock the potential of our discoveries and empower us to perform the translation research needed to rapidly identify the cause of each individual cancer, advancing scientific discovery and allowing a more accurate prediction of the best cancer treatments for individual patients."
SCIEX will designate ProCan as a "SCIEX Centre of Innovation in Precision Medicine" and will include SCIEX scientists working with researchers from CMRI to develop and trial new omics workflows in a real-world setting. SCIEX and CMRI will discuss further details about the centre at the 21st Annual Lorne Proteomics Symposium 2016."
Scientists from SCIEX will be presenting Multi-Omics workshops and poster presentations at the 21st Annual Lorne Proteomics Symposium 2016, held February 4th through the 7th at Mantra Lorne, Lorne Victoria.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com.
For research use only. Not for use in diagnostic procedures
AB Sciex is operating as SCIEX.
© 2015 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.
Children's Medical Research Institute (CMRI) conducts fundamental research to understand the genes involved in human health and development and the underlying causes of disease. ProCan™ expands upon other ACRF-funded facilities at CMRI, and combined with the Centre for Kinomics and the Telomere Analysis Centre comprises The ACRF Cancer Centre. CMRI is also at the forefront of international research in the areas of embryonic development and birth defects, cancer, neurobiology, and gene therapy. Find out more at www.cmri.org.au
Manager, Global Public Relations and Brand, SCIEX
Sniper Public Relations on Behalf of SCIEX
A new password has been sent to your email.
You have added a user.
This serial number could not be found. Would you like to submit the case anyway?
Your password has been updated.
Your account is now created.
A verification link has been sent to your email.
A new password has been sent to your email.
Your insturment has been removed.
Your privacy settings are now updated.
Software has already been registered to another instrument. Please check your AID and try again.
If you want to change the License Key to another instrument, please submit a new case.
Software has already been registered to the instrument selected.
Please check your instrument's software by going to the Instruments page and selecting the instrument in your "My Instruments" section. Here you will see a Software tab where you can view your instrument's software information.
You can also go to the Registered Software page to view software associated with your instrument(s).
If you are not finding what you are looking for, please submit a new case.